Therapeutic Drug Monitoring

Breakthrough technology to enhance monoclonal antibody-based treatment

Labelled Nivolumab-like 13C15N


Absolute quantification of Opdivo® or its biosimilars

Specific labelling

Arginine: 13C6,15N4, >99%

Lysine: 13C6,15N2, >99%

10 µg     ->    650 €      Quantity  

You must sign in or create an account to order this product


Nivolumab is a fully human IgG4 monoclonal antibody that acts as an immunomodulator by blocking ligand activation of programmed cell death 1 (PD-1) receptor on T cells. The average weight of the antibody is 143,6kDa. The Nivolumab-like stable isotope labelled standard is suited for quantifying Nivolumab in human serum samples.


The mAb-like technology is patented.